bilastine has been researched along with Rhinitis, Allergic, Nonseasonal in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 12 (92.31) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wolthers, OD | 1 |
| Braido, F; Canonica, GW; Ferrando, M; Sclifò, F | 1 |
| Kiss, I; Kuna, P; Novák, Z; Tortajada-Girbés, M; Valiente, R; Yáñez, A | 1 |
| Gotoh, M; Ohashi, Y; Okubo, K; Saito, A; Togawa, M | 1 |
| Kruszewski, J | 1 |
| Mullol, J; Sastre, J; Valero, A; Valiente, R | 1 |
| Ansótegui, I; Bachert, C; Baena-Cagnani, CE; Bousquet, J; Canonica, GW; Church, MK; Cruz, AA; González, SN; Kuna, P; Morais-Almeida, M; Mullol, J; Ryan, DP; Sánchez-Borges, M; Valiente, R; Zuberbier, T | 1 |
| Valero Santiago, AL | 1 |
| Bartra, J; Dávila, I; del Cuvillo, A; Ferrer, M; Jáuregui, I; Montoro, J; Mullol, J; Sastre, J; Valero, A | 2 |
| Bartra, J; Dávila, I; del Cuvillos, A; Ferrer, M; Jáuregui, I; Montoro, J; Mullol, J; Sastre, J; Valero, A | 1 |
| Carter, NJ | 1 |
| Scaglione, F | 1 |
8 review(s) available for bilastine and Rhinitis, Allergic, Nonseasonal
| Article | Year |
|---|---|
New therapies for allergic rhinitis.
Topics: Administration, Intranasal; Androstadienes; Anti-Allergic Agents; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal, Humanized; Benzimidazoles; Butyrophenones; Cyproheptadine; Fluticasone; Histamine H1 Antagonists; Humans; Omalizumab; Phthalazines; Piperidines; Pregnenediones; Rhinitis, Allergic; Rhinitis, Allergic, Perennial | 2014 |
[Antihistamines in the treatment of allergic rhinitis--update 2008/2009].
Topics: Administration, Inhalation; Anti-Allergic Agents; Benzimidazoles; Clinical Trials as Topic; Drug Combinations; Glucocorticoids; Histamine Antagonists; Humans; Piperidines; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal | 2009 |
Establishing the place in therapy of bilastine in the treatment of allergic rhinitis according to ARIA: evidence review.
Topics: Adolescent; Adult; Anti-Allergic Agents; Asthma; Benzimidazoles; Child; Humans; Piperidines; Practice Guidelines as Topic; Rhinitis, Allergic, Perennial | 2012 |
Effect of bilastine upon nasal obstruction.
Topics: Benzimidazoles; Clinical Trials as Topic; Histamine H1 Antagonists; Humans; Nasal Obstruction; Piperidines; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal | 2011 |
Bilastine and quality of life.
Topics: Benzimidazoles; Chronic Disease; Histamine H1 Antagonists; Humans; Piperidines; Quality of Life; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Urticaria | 2011 |
Effect of bilastine upon the ocular symptoms of allergic rhinoconjunctivitis.
Topics: Benzimidazoles; Conjunctivitis, Allergic; Histamine H1 Antagonists; Humans; Immunoglobulin E; Piperidines; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal | 2011 |
Bilastine: in allergic rhinitis and urticaria.
Topics: Area Under Curve; Benzimidazoles; Cetirizine; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Piperidines; Randomized Controlled Trials as Topic; Rhinitis, Allergic, Perennial; Urticaria | 2012 |
Safety profile of bilastine: 2nd generation H1-antihistamines.
Topics: Animals; Automobile Driving; Benzimidazoles; Conjunctivitis, Allergic; Drug Interactions; Histamine H1 Antagonists, Non-Sedating; Humans; Piperidines; Rhinitis, Allergic; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Treatment Outcome; Urticaria; Wakefulness | 2012 |
3 trial(s) available for bilastine and Rhinitis, Allergic, Nonseasonal
| Article | Year |
|---|---|
Safety and tolerability of bilastine 10 mg administered for 12 weeks in children with allergic diseases.
Topics: Adolescent; Adult; Benzimidazoles; Child; Child, Preschool; Chronic Disease; Double-Blind Method; Female; Follow-Up Studies; Histamine H1 Antagonists, Non-Sedating; Humans; Male; Piperidines; Rhinitis, Allergic, Perennial; Treatment Outcome; Urticaria | 2016 |
Long-term safety and efficacy of bilastine following up to 12 weeks or 52 weeks of treatment in Japanese patients with allergic rhinitis: Results of an open-label trial.
Topics: Adult; Benzimidazoles; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Japan; Male; Middle Aged; Piperidines; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Treatment Outcome | 2017 |
Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo in the treatment of perennial allergic rhinitis.
Topics: Adolescent; Adult; Aged; Anti-Allergic Agents; Argentina; Benzimidazoles; Cetirizine; Child; Dosage Forms; Double-Blind Method; Drug Administration Schedule; Europe; Female; Humans; Male; Middle Aged; Piperidines; Placebos; Rhinitis, Allergic, Perennial; South Africa; Treatment Outcome; Young Adult | 2012 |
2 other study(ies) available for bilastine and Rhinitis, Allergic, Nonseasonal
| Article | Year |
|---|---|
Bilastine: a new nonsedating oral H1 antihistamine for treatment of allergic rhinoconjunctivitis and urticaria.
Topics: Administration, Oral; Benzimidazoles; Child; Conjunctivitis, Allergic; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Male; Piperidines; Rhinitis, Allergic; Rhinitis, Allergic, Perennial; Urticaria | 2013 |
Focusing into new challenges in allergic rhinitis and urticaria. Introduction.
Topics: Benzimidazoles; Histamine H1 Antagonists; Humans; Piperidines; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Urticaria | 2011 |